David Fleischer - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock David Fleischer's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayDavid Fleischer
Verified
Planner, IBI Group
Vaughan
Beats
News , Opinions, Movies, Comics , Reviews, Art , Video Games
ScienceFinanceTech
Content
By Richard Gawel Verified, Kristen Dowd Verified, David Fleischer| Healio Allergy/Asthma Verified Key takeaways: The VP250 VIASKIN Peanut patch includes 250 µg of peanut protein. Percentages of children who achieved a 1,000 mg eliciting dose increased. Levels of peanut-specific IgE and IgG4 levels decreased and increased. SAN DIEGO — Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract presented here.
By Norbert Goldfield, David Fleischer| MedCentral@ At the Democratic National Convention, there was a great deal of talk about the role of neighbors.
By Richard Gawel Verified, Kristen Dowd Verified, David Fleischer| Healio Allergy/Asthma Verified Key takeaways: The VP250 VIASKIN Peanut patch includes 250 µg of peanut protein. Percentages of children who achieved a 1,000 mg eliciting dose increased. Levels of peanut-specific IgE and IgG4 levels decreased and increased. SAN DIEGO — Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract presented here.